Literature DB >> 16489907

5. Recent advances in sports medicine.

Peter D Brukner1, Kay M Crossley, Hayden Morris, Simon J Bartold, Bruce Elliott.   

Abstract

New research has changed our perception and management of common injuries. Magnetic resonance imaging and arthroscopy of the hip have shown that labral injuries, chondral injuries, rim lesions, synovitis and tears of the ligament teres are common causes of hip, groin and low-back pain. Hip arthroscopy is used both as a diagnostic and therapeutic tool; it has been shown to be of benefit in recent traumatic labral injury, but disappointing in the management of chronic hip pain (which may be associated with degenerative change, and chondral lesions of the acetabulum). The McConnell multimodal physiotherapy regimen is effective in treating patellofemoral pain. Anterior cruciate ligament rupture is three to five times more common in women, but neuromuscular training appears to decrease its incidence. Patellar tendon and hamstring grafts appear to be equally effective in anterior cruciate ligament reconstruction. Articular cartilage defects remain a significant problem, and the efficacy of treatments such as autologous chondrocyte implantation is still unclear.

Entities:  

Mesh:

Year:  2006        PMID: 16489907

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Physical activity is associated with a low prevalence of musculoskeletal disorders in the Royal Norwegian Navy: a cross sectional study.

Authors:  Tone Morken; Nils Magerøy; Bente E Moen
Journal:  BMC Musculoskelet Disord       Date:  2007-07-02       Impact factor: 2.362

2.  Effect of physical activity on musculoskeletal discomforts among handicraft workers.

Authors:  Mahnaz Shakerian; Masoud Rismanchian; Pejman Khalili; Akram Torki
Journal:  J Educ Health Promot       Date:  2016-06-23

3.  Upsurge of Sports Injuries and Their Treatment.

Authors:  Raju Vaishya; Ish Kumar Dhammi
Journal:  Indian J Orthop       Date:  2017 Sep-Oct       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.